Alexandra Forestier

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study

Guillaume Manson, Alexandre Maria, F. Poizeau et al. · Journal for ImmunoTherapy of Cancer · 2019 · 106 citations · Full text

Life Sciences, Immunology, Oncology +17

Moderate-to-severe eosinophilia induced by treatment with immune checkpoint inhibitors: 37 cases from a national reference center for hypereosinophilic syndromes and the French pharmacovigilance database

Quentin Scanvion, Johana Béné, Sophie Gautier et al. · OncoImmunology · 2020 · 58 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Anti–programmed death ligand 1 immunotherapies in cancer patients with pre-existing systemic sclerosis: A postmarketed phase IV safety assessment study

Marion Panhaleux, Olivier Espitia, Benjamin Terrier et al. · European Journal of Cancer · 2021 · 46 citations

Medicine, Immunology, Oncology +16

Evolution of high-resolution CT-scan in systemic sclerosis-associated interstitial lung disease: Description and prognosis factors

Alexandra Forestier, N. Le Gouellec, Hélène Behal et al. · Seminars in Arthritis and Rheumatism · 2020 · 34 citations · Full text

Medicine, Internal Medicine, Radiology +14